Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Fink, M.
Major adverse cardiovascular events in patients with cancer treated with immune checkpoint inhibitors
Humanmedizin; [ Diplomarbeit ] Medizinische Universität Graz; 2025. pp. 54 [OPEN ACCESS]
FullText

Authors Med Uni Graz:
Advisor:: Moik Florian; Riedl Jakob
Altmetrics:
Abstract:: Background: Patients with cancer treated with immune checkpoint inhibitors (ICI) are at risk of developing immune-related adverse events. Accumulating evidence shows that ICI therapy might progress inflammatory processes and cause atherosclerosis leading to major adverse cardiovascular events (MACE).